Everstone‑backed Integris Medtech gets SEBI nod for IPO
The Everstone Capital–backed company, India’s second‑largest home‑grown diversified medtech platform by FY25 operating revenue, plans to raise up to Rs 925 crore through a fresh issue of shares, alongside an offer for sale of 21.67 million shares from existing investors and founders.
Integris Medtech, Anjali Labtech, APPL Containers, Alpine Texworld IPOs get approval from SEBI
SEBI has issued observations on the draft papers of Integris Medtech on February 13, and Anjali Labtech on February 17, while the observations issued by the regulator on draft document of APPL Containers, and Alpine Texworld on February 20.
The Reading List: February 20, 2026
Our research and opinion teams have curated a selection of articles and social media gems from the world of economy, business and finance for your weekend read
OPINION | Beyond Traceability: Making battery aadhaar strategically transformative
Battery Aadhaar can improve mineral governance and promote circularity. But without strong upstream strategy, MSME support and integration of the informal sector, traceability alone cannot ensure real energy security
Miltenyi Biotec sees big India opportunity as it advances Made‑for‑India CAR‑T therapies
Miltenyi is preparing to bring its pipeline of cancer and autoimmune‑targeted therapies to India.
Omnitech Engineering sets price band at Rs 216-227 per share for its Rs 583-crore IPO
Omnitech Engineering IPO | The initial public offering is a mix of fresh issue of shares worth Rs 418 crore, and an offer-for-sale of Rs 165 crore worth shares.
Medikabazaar looks to raise $50 million to fund next phase of growth
Medikabazaar is currently in discussions to raise $50 million in fresh capital, with $25 million already committed by existing investors.
Gaudium IVF mobilises Rs 49.5 crore via anchor book, Rs 165-crore IPO to open on February 20
Gaudium IVF IPO | The company is raising Rs 165 crore via initial public offering which comprises of fresh issue of 1.13 crore equity shares worth Rs 90 crore, and an offer-for-sale of 94.93 lakh shares amounting to Rs 75 crore by promoter.
Upcoming IPO | Omnitech Engineering IPO to hit Dalal Street on February 25, offer size reduced by over 30%
Omnitech Engineering IPO | The public issue is a combination of fresh issuance of shares worth Rs 418 crore, and an offer-for-sale of Rs 165 crore worth shares by promoter Udaykumar Arunkumar Parekh.
Gaudium IVF IPO opens tomorrow: GMP signals decent listing; key things to know before you apply
Gaudium IVF IPO GMP: The allotments are likely to be finalised by February 25, and the shares are scheduled to be listed on stock exchanges on February 27.
ONGC, Oil India shares jump up to 7% as rising US-Iran tensions push oil prices higher; HPCL, BPCL fall up to 4%
Oil prices are rallying as investors remain concerned over the possibility of US action against Iran.
Bank Nifty falls 1%, breaches key support levels amid overall market downturn: Check key trading levels
The Nifty Bank index has slipped below the 61,000 mark, snapping a three-session gaining streak.
Small, midcap stocks plunge up to 5% amid overall market weakness: Check top losers
Given persistent global uncertainties and elevated market volatility, traders are advised to maintain discipline and be selective, focusing on fundamentally strong stocks during market corrections, an analyst said.
HDFC Securities Reli Discusses Impact of Tighter Bank Financing On Capital mkt Stocks
Dhiraj Relli, MD & CEO of HDFC Securities, shares his perspective on the RBI’s decision to tighten lending norms for brokers effective April 1 and what it means for capital market players. With stricter bank financing and changes around cash collateral usage, the move is expected to impact trading activity, especially in the derivatives segment.
Relli explains how higher funding costs and reduced leverage could make intra-day trading more expensive, potentially leading to a 15–20% decline in F&O volumes. Prop traders and highly leveraged participants may feel the pressure first, raising concerns over earnings visibility for brokerage firms and other capital market-linked stocks.
The discussion also delves into whether the earnings hit will be short-term or structural, and how investors should approach capital market names amid evolving regulatory norms.
Sensex, Nifty tumble nearly 1.5%: Trump's possible action against Iran leaving markets jittery, say analysts
In the short run, we can expect a range-bound market with high volatility, an analyst said.
Sensex falls 1,200 pts, Nifty down 1.4%: Will bear attack continue or can bulls make a comeback? Analysts suggest trading levels
Nifty 50 has broken a key support level of 25,650 which was suggested by analysts.
Upcoming IPOs: Clean Max, PNGS Reva Diamond among 3 mainboard IPOs opening next week, check latest GMP
IPO news: The maiden public issue of Gaudium IVF will spill over from this week, after opening tomorrow (February 20).
Infosys, TCS, Coforge other IT stocks rise up to 2% after Wall Street tech rally
IT stocks: Today's rise comes after a massive tech selloff after Anthropic’s launch of new AI tools, leading to worries about an AI-led disruption in the sector.
Gold, silver ETFs jump up to 4% as precious metals rise: What lies ahead?
This comes despite a muted sentiment in global commodity prices on a firm dollar ahead of key US inflation data that could influence the Federal Reserve's interest rate-cutting trajectory.
Yotta Data Services to spend $2 billion on Nvidia chips
Yotta Data Services currently operates over 10,000 Nvidia GPUs, with another 8,000 set to go live next quarter, and plans to scale beyond 80,000 GPUs by FY27 as India expands its AI infrastructure footprint.
Kiaasa Retail IPO to open on February 23, plans to fund stores expansion
Kiaasa Retail IPO | The company is valued at Rs 231.50 crore at the upper price band. The offer comprises of entirely fresh issue of 54.90 lakh equity shares.
Dr. Reddy’s preps semaglutide pill launch in FY27, as GLP‑1 market opens up in India
“We are ready with all formats, including the oral,” says M.V. Ramana, CEO of Branded Markets (India & Emerging Markets). Semaglutide is already approved by India’s Subject Expert Committee (SEC), and Dr. Reddy’s is now awaiting the final nod from the national drug regulator, the CDSCO.
Upcoming IPOs: Clean Max Enviro's GMP falls below 1%, Gaudium IVF's GMP indicates decent listing
Clean Max Enviro IPO will open on February 23, while that of Gaudium IVF will open on February 20.
Fractal Industries IPO subscribed 5.13 times on final day; listing likely next week
Fractal Industries IPO | Investors have put in bids for 83.28 lakh shares against offer size of 16.23 lakh shares via 3,270 applications during February 16-18.
Kwality Wall's shares jump 5%, snap two-session losing streak
Kwality Wall’s share price: On its debut day, the stock had gained around 5% to Rs 31.29 apiece, the highest level seen by it so far.
